Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by stockman6767on Apr 18, 2019 11:10am
153 Views
Post# 29644531

Copy of another comment I sent to SA on the ABBOTT article

Copy of another comment I sent to SA on the ABBOTT article
Yet another piece of information in this sad story was made known to me. I had wondered how the SALP debt was shown as $229 MILLION, all I recalled was about $120 Million due in 2019 – how did that magically grow from about $120 Million ($100 Mil US) to $229 MILLION?  You will note that they just recently extended the loan to 2024 which at the time was taken as a relief and that the balance sheet issue was solved until the revenue would start to flow. Now with hindsight it is obvious that this was really a further treacherous move on the part of  SALP to claim ALL THE UNEARNED INTEREST AT THE TIME OF THE RESTRUCTURE THAT THEY CLAIM IMPROPERLY ABOUT DOUBLES THE OUTSTANDING LOAN. SO THEY ARE TAKING ANOTHER APPROX  $110 MILLION WHICH MEAN ANOTHER STOLEN 7.23 BILLION SHARES FOR IMAGINARY INTEREST NEVER EARNED WHATSOEVER.
 
What clever thievery, by extending the loan period out to 2024 for the planned pretext of claiming 5 years of interest AT 10% per annum for a period that the loan never existed for, with the intent of using this as a pretext in order to collect about another about 7.5 BILLION shares or about another 30% of the company for NO REASON WHATSOEVER. Throw that into your tables of percentages owned of the company MR. Abbott. And they are so intent on capping the rights offering to the current investors at $75 Mil (about 4 Bil shares) while they themselves virtually stole over 7 Bil shares. The whole thing smells very foul and if the canadian and Quebec and Ontario authorities allow this to go forward no one will ever trust the Canadian security markets again!!! And the clincher is the application fo the TSX for a "hardship" case in order to put this through WITHOUT EVEN ALLOWING THE SHAREHOLDERS TO GET THEIR VOTE ON THIS CRUCIAL MATTER WHICH THEY ARE ENTITLES TO. THEY KNOW THEY WOULD LOSE SUCH A VOTE AND THIS IS WHY THE MOVE FOR THE "HARDSHIP" APPLICATION.
 
Truly thievery at a level unimagined from the poor unsuspecting retail investor by SALP, owned by some members of the wealthiest family in Canada.wealthiest family!
 
Bullboard Posts